Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183339 · ClinicalTrials.gov registry record · Phase 2
Early Intervention With Fluoxetine in Autism
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00183339 is a Phase 2 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 18 participants.
The verdict
NCT00183339, a Phase 2 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.
Interventions
- DRUG Placebo
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-07 |
| Est. Completion | 2008-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183339
The ClinicalTrials.gov registry entry for NCT00183339 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00183339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183339 about?
NCT00183339 is a clinical study titled "Early Intervention With Fluoxetine in Autism". This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.
What is the current status of trial NCT00183339?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2005-07. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00183339?
The interventions under investigation include: Placebo (DRUG), Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00183339?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.